The 20th Anniversary of Peak Pharmaceutical
Release time:
2020-08-14
Peak Pharmaceutical 20rd Anniversary memorabilia
1998
12 April 31 , Zhejiang Peak Pharmaceutical Co., Ltd. was incorporated.
1999
7 , donated 3 yuan to support the medical cause in Naqu region of Tibet.
9 April 11 , held a pharmaceutical development work seminar in Hangzhou to discuss the development strategy of peak pharmaceutical industry.
9 January 30 , bought out Jinhua pharmaceutical co., ltd. for 2208 yuan.
In December , Tianjin Jianfeng Natural Products Research and Development Co., Ltd., a natural plant extraction enterprise, was invested in Tianjin.
won the title of "double top ten" enterprise in Zhejiang pharmaceutical industry.
sales revenue and total profit ranked 35 and 33 respectively in the national chemical pharmaceutical industry.
2000
3# In March, the first new drug clarithromycin capsule obtained the production approval, and 6# was officially produced and put on the market in July.
8 14 , Jinhua Jianfeng Pharmacy Chain Co., Ltd. was established on the basis of the original stores of Jinhua Pharmaceutical Company.
8 July 26 , the first sterile full-automatic sub-packaging production line for cephalosporin powder injection passed the national GMP acceptance.
was rated as the top ten industrial enterprises in Zhejiang Province and the top ten pharmaceutical enterprises in Zhejiang Province (ranked sixth). In
12 , China's first national class I new drug gatifloxacin, jointly developed with China Pharmaceutical University, was protected by the national clinical bulletin with a protection period of 12 years and was listed as a major provincial and municipal scientific and technological research project.
March# In November, azithromycin freeze-dried powder injection, a national four-class new drug, was officially put into production in Jiangnan Pharmaceutical Factory.
13 , Qiubin Pharmaceutical Base Project broke ground. December 12# May
, Jiangnan Pharmaceutical Factory's three workshops and five dosage forms passed the national GMP certification.
1
, donated 28 sets of pharmaceutical equipment worth nearly one million yuan to Moyu County in Xinjiang to support local economic construction. 1 September
, the second lyophilized powder injection amiodarone hydrochloride obtained the new drug certificate. August June, the national new drug Yufeng Ningxin Dropping Pills was approved to be listed, which is the first to be listed in China, filling the gap of this dosage form in the province.
August January, was recognized as Jinhua high-tech enterprises.
October June, the first-line cardiovascular antihypertensive drug Lestat (amlodipine aspartate tablets) was officially listed.
12 January
, Qiubin Pharmaceutical Factory passed the national GMP certification and was the largest single pharmaceutical factory in East China at that time. 12
, then Secretary of the Zhejiang Provincial Party Committee and Acting Governor Xi Jinping inspected Jianfeng Pharmaceutical.
1# In March, the national first-class new drug Leo (gatifloxacin) was officially put on the market.
May August 14
28 .02 million yuan to designated hospitals for SARS prevention such as Jinhua Central Hospital, Jinhua People's Hospital and Jinhua Hospital of Traditional Chinese Medicine. 6 , was recognized as a high-tech enterprise in Zhejiang Province.
August December, China Pharmaceutical Enterprise Management Association and China Pharmaceutical Entrepreneurs Association jointly released a list of the top 100 pharmaceutical enterprises in the country, with Jianfeng Pharmaceutical ranked 49
2004
May, the third generation antidepressant sultano (paroxetine) was officially launched.
5 19
7 July 15
August April, two new drugs, cefmenoxime hydrochloride for injection and glycerol fructose injection, successfully obtained production approval. 10
9 January, won the honorary title of "Zhejiang Province Model Collective.
2005
February 17
2004 Jinhua Drug GMP Certification Advanced Unit". 2006
September 19
2007
February 4
10 September, through the national torch plan key high-tech enterprise review, become a national key high-tech enterprise.
October April 27
2008
More information
In the eastern corner of the production area of Jianfeng Health Technology Company, there is a very inconspicuous building. From below, only a few pipes of uneven thickness can be seen on the top and the slogan "Focus on Environmental Protection and Promote Sustainable Development" with red letters on the yellow background on the stainless steel guardrail. Walking up, you can only see several closed pools and a small room with stacks of documents, test tubes, glass bottles and other testing tools on the table. This is the peak and healthy sewage treatment station. The production sewage of the whole factory area is concentrated here. After adjustment (PH adjustment), pre-acidification, anaerobic, anoxic, aerobic (aeration), precipitation and other links, it is discharged into the pipe network after reaching the special discharge standard. Yin Zhiwu, executive deputy general manager of Jianfeng Health, said that because the sewage treatment station in Wucheng District has not yet been built, Jianfeng Health has not yet been able to achieve pipe discharge, and the relevant national laws have strict requirements on the discharge of water pollutants from the extraction pharmaceutical industry. Sewage discharge must reach a special discharge limit, that is, chemical oxygen demand (COD) must be less than 50 mg/L. Enterprise development and environmental protection are both the concept of peak health since its establishment. In March this year, on the basis of the original environmental protection facilities, Jianfeng Health carried out technical renovation of waste gas collection and treatment facilities, and at the same time installed a sealing cover on the sewage treatment station to realize the closed collection of waste gas. Since the trial operation of this facility in mid-May, the overall effect has been obvious. The original treatment tank would emit an unpleasant smell during work, but now the smell has been significantly reduced. Compared with the young enterprise of peak health, the relatively "older" peak pharmaceutical has more experience in sewage treatment and environmental protection. Akihama
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-30
Jianfeng Pharmaceutical Won Advanced Collective of Municipal Red Cross Humanitarian Promotion Award
On April 24, the Red Cross Society of Jinhua issued a circular commending the advanced units and individuals of the 2016 Red Cross Humanitarian Promotion Award. Peak Pharmaceutical Company won the Red Cross Humanitarian Promotion Award for Advanced Collective. The Red Cross is a social relief organization engaged in humanitarian work, with the purpose of carrying forward the spirit of humanity, fraternity and dedication, protecting human life and health, and promoting the cause of peace and progress of mankind. As a socially responsible enterprise, Jianfeng Pharmaceutical has always attached importance to public welfare and charity work, vigorously promoted the spirit of the Red Cross, and vigorously supported the work of the Red Cross with practical actions. In September 2016, at the theme publicity activity of "World First Aid Day" and the opening ceremony of the municipal Red Cross emergency rescue station (point), Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, donated 6 AEDs known as "life-saving artifact" to the Red Cross on behalf of Jianfeng Pharmaceutical, it is equipped with six Red Cross emergency rescue service stations (points), namely, Jinhua high-speed railway station, sports center, cultural center, Shuanglong scenic spot, Siping village scenic spot and Suoyuan village scenic spot. The configuration of AED equipment has played a very good role in improving the emergency rescue capacity of Jinhua's key locations, and has been affirmed by the Red Cross and related units. (Spike Pharmaceuticals)
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31